*****
TODAY’S NEWS:
Could low-dose Avandia be useful in preventing diabetes onset? This would be good news for GSK – GlaxoSmithKline Plc’s Avandia helped prevent the onset of diabetes when taken at a low dose with another drug, according to a company-sponsored study that suggests the regimen may help patients without raising heart attack risk. Half doses of Avandia and the therapy metformin, when combined, cut the risk of developing diabetes by two-thirds compared with placebo, Canadian researchers said..more
We’re in the gusher phase of the pre-ASCO press release flood. This sneak peek on BMS products is intriguing. More here – Four Scenarios for BMS.
Lying about data – people just don’t seem to learn. Sigh. And that goes for financial folks, politicians, climate scientists – it ain’t just pharma, folks!
Cephalon, Provigil and Nuvigil.
RECOMMENDED
Leadership Training. We’ve got the vendor/partners you need for this – field leaders or executive leadership level. Contact us (stevew at impactiviti dot com, or phone at 973-947-7429) for recommendations.
PLUS
New iPhone app released by Novartis subsidiary CibaVision. My “live” review while playing with it – mixed feelings. And, while we’re doing reviews – a north Jersey restaurant (Tabor Road Tavern) that blew me away.
JUST FOR FUN
Who needs PSA tests for prostate cancer when you have Fido? What’s interesting is that this is – amusingly – serious!
———-
Subscribe to the Impactiviti blog via e-mail (which will bring you Impactiviti Daily – a brief of the day’s top pharma news)
Visit the Impactiviti Job Board
Sign up for the Impactiviti Connection twice-monthly e-newsletter (see sample)
*****
Impactiviti blog 